These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1808111

  • 1. Manganese-DPDP as a hepatobiliary contrast agent in the magnetic resonance imaging of liver tumors. Results of clinical phase II trials in Germany including 141 patients.
    Rummeny E, Ehrenheim C, Gehl HB, Hamm B, Laniado M, Lodemann KP, Schmiedel E, Steudel A, Vogl TG.
    Invest Radiol; 1991 Nov; 26 Suppl 1():S142-5; discussion S150-5. PubMed ID: 1808111
    [No Abstract] [Full Text] [Related]

  • 2. Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
    Bernardino ME, Young SW, Lee JK, Weinreb J.
    Invest Radiol; 1991 Nov; 26 Suppl 1():S148-9; discussion S150-5. PubMed ID: 1808113
    [No Abstract] [Full Text] [Related]

  • 3. [Manganese DPDP as a contrast medium for MR tomography of focal liver lesions. Tolerance and image quality in 20 patients].
    Kopp AF, Laniado M, Aicher KP, Grönewäller EF, Claussen CD.
    Rofo; 1992 Dec; 157(6):539-47. PubMed ID: 1457788
    [Abstract] [Full Text] [Related]

  • 4. [Manganese-DPDP in the MR tomography of malignant liver tumors. The initial results with a new hepatobiliary contrast agent].
    Steudel A, Layer G, Kraheck H, Hartlapp J, Reiser M.
    Rofo; 1992 May; 156(5):460-4. PubMed ID: 1596550
    [Abstract] [Full Text] [Related]

  • 5. Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
    Rofsky NM, Earls JP.
    Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):73-85. PubMed ID: 8673718
    [Abstract] [Full Text] [Related]

  • 6. [The clinical value of Mn-DPDP: a new paramagnetic hepatobiliary contrast medium for magnetic resonance tomography of the liver].
    Vogl TJ, Hamm B, Schnell B, Eibl-Eibesfeldt B, Steiner S, Lissner J.
    Rofo; 1991 Dec; 155(6):568-74. PubMed ID: 1764599
    [Abstract] [Full Text] [Related]

  • 7. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP.
    Suto Y, Weinreb JC, Rofski NM.
    J Comput Assist Tomogr; 1996 Dec; 20(4):647-9. PubMed ID: 8708073
    [Abstract] [Full Text] [Related]

  • 8. Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
    Rofsky NM, Weinreb JC.
    Magn Reson Q; 1992 Sep; 8(3):156-68. PubMed ID: 1390058
    [Abstract] [Full Text] [Related]

  • 9. The need for effective contrast agents to enhance the performance of MR imaging.
    Grant D, Refsum H, Rummeny E, Marchal G.
    Acta Radiol; 1997 Jul; 38(4 Pt 2):623-5. PubMed ID: 9245954
    [No Abstract] [Full Text] [Related]

  • 10. Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients.
    Aicher KP, Laniado M, Kopp AF, Grönewäller E, Duda SH, Claussen CD.
    J Magn Reson Imaging; 1993 Jul; 3(5):731-7. PubMed ID: 8400558
    [Abstract] [Full Text] [Related]

  • 11. Mn-DPDP enhancement patterns of hepatocellular lesions on MR images.
    Vogl TJ, Hamm B, Schnell B, McMahon C, Branding G, Lissner J, Wolf KJ.
    J Magn Reson Imaging; 1993 Jul; 3(1):51-8. PubMed ID: 8381314
    [Abstract] [Full Text] [Related]

  • 12. Unexpected MR-T1 enhancement of endocrine liver metastases with mangafodipir.
    Mathieu D, Coffin C, Kobeiter H, Caseiro-Alves F, Mahfouz A, Rahmouni A, Diche T.
    J Magn Reson Imaging; 1999 Aug; 10(2):193-5. PubMed ID: 10441024
    [Abstract] [Full Text] [Related]

  • 13. Mn-DPDP-enhanced 24-h delayed-scan MRI of hepatocellular carcinoma is correlated with histology.
    Wang DB, Zhou KR, Zeng MS, Chen KM, Wang YX.
    Eur Radiol; 2004 Apr; 14(4):743-5. PubMed ID: 12802614
    [No Abstract] [Full Text] [Related]

  • 14. Contrast-enhanced MR imaging of the liver.
    Saini S.
    Radiology; 1992 Jan; 182(1):12-4. PubMed ID: 1727273
    [No Abstract] [Full Text] [Related]

  • 15. Diagnostic efficacy of MnDPDP in MR imaging of the liver. A phase III multicentre study.
    Wang C, Ahlström H, Ekholm S, Fagertun H, Hellström M, Hemmingsson A, Holtås S, Isberg B, Jonnson E, Lönnemark-Magnusson M, McGill S, Wallengren NO, Westman L.
    Acta Radiol; 1997 Jul; 38(4 Pt 2):643-9. PubMed ID: 9245958
    [Abstract] [Full Text] [Related]

  • 16. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP.
    Gallez B, Bacic G, Swartz HM.
    Magn Reson Med; 1996 Jan; 35(1):14-9. PubMed ID: 8771018
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging.
    Rofsky NM, Weinreb JC, Bernardino ME, Young SW, Lee JK, Noz ME.
    Radiology; 1993 Jul; 188(1):53-9. PubMed ID: 8390072
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
    Bernardino ME, Young SW, Lee JK, Weinreb JC.
    Radiology; 1992 Apr; 183(1):53-8. PubMed ID: 1549694
    [Abstract] [Full Text] [Related]

  • 20. [MR and biliary tract].
    Chabanova E, Møller JM, Løgager V, Thomsen HS.
    Ugeskr Laeger; 2005 Aug 29; 167(35):3321-2; author reply 3322-3. PubMed ID: 16138986
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.